» Articles » PMID: 36689568

Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank

Overview
Journal Circulation
Date 2023 Jan 23
PMID 36689568
Authors
Affiliations
Soon will be listed here.
Citing Articles

High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression.

Resar L, Luo L Int J Mol Sci. 2025; 26(5).

PMID: 40076747 PMC: 11899949. DOI: 10.3390/ijms26052125.


Clonal haematopoiesis of indeterminate potential: an emerging risk factor for type 2 diabetes and related complications.

Zuriaga M, Fuster J Diabetologia. 2025; .

PMID: 40064675 DOI: 10.1007/s00125-025-06393-8.


Clonal hematopoiesis of indeterminate potential, health indicators, and risk of cardiovascular diseases among patients with diabetes: a prospective cohort study.

Sun Y, Yu Y, Cai L, Yu B, Xiao W, Tan X Cardiovasc Diabetol. 2025; 24(1):72.

PMID: 39948662 PMC: 11827465. DOI: 10.1186/s12933-025-02626-7.


Evaluation of clonal hematopoiesis and mosaic loss of Y chromosome in cardiovascular risk: An analysis in prospective studies.

Fawaz S, Marti S, Dufossee M, Pucheu Y, Gaufroy A, Broitman J Elife. 2024; 13.

PMID: 39665621 PMC: 11637461. DOI: 10.7554/eLife.96150.


A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis.

Haque T, Shastri A, Desai P, Xie Z, Hammond D, King Z Br J Haematol. 2024; 206(2):416-427.

PMID: 39653653 PMC: 11829135. DOI: 10.1111/bjh.19925.


References
1.
Jaiswal S, Natarajan P, Silver A, Gibson C, Bick A, Shvartz E . Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017; 377(2):111-121. PMC: 6717509. DOI: 10.1056/NEJMoa1701719. View

2.
Bick A, Pirruccello J, Griffin G, Gupta N, Gabriel S, Saleheen D . Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis. Circulation. 2019; 141(2):124-131. PMC: 7008855. DOI: 10.1161/CIRCULATIONAHA.119.044362. View

3.
Svensson E, Madar A, Campbell C, He Y, Sultan M, Healey M . TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial. JAMA Cardiol. 2022; 7(5):521-528. PMC: 8988022. DOI: 10.1001/jamacardio.2022.0386. View

4.
Vlasschaert C, Mack T, Heimlich J, Niroula A, Uddin M, Weinstock J . A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets. Blood. 2023; 141(18):2214-2223. PMC: 10273159. DOI: 10.1182/blood.2022018825. View